N/A
Completed N=117
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
Source: ClinicalTrials.gov NCT02698436 ↗Enrolled (actual)
117
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcomePrimary: Percent Change of Global Face Total Acne Lesion Count From Baseline — -44; -54 Percent change of acne lesion count
Summary
This study will compare two different acne treatments for the treatment of acne. Half of the participants will receive two marketed acne products (cleanser and leave-on topical treatment), while the other half of the participants will receive a marketed cleanser and a light-therapy device.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change of Global Face Total Acne Lesion Count From Baseline |
-44; -54 | — |
| SECONDARY Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 1 |
-19; -26 | — |
| SECONDARY Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 2 |
-28; -42 | — |
| SECONDARY Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 4 |
-35; -46 | — |
| SECONDARY Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 8 |
-40; -50 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Baseline |
47.2; 47.6 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Week 1 |
39.2; 36.8 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Week 2 |
35.3; 30.5 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Week 4 |
30.5; 27.0 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Week 8 |
27.8; 26.4 | — |
| SECONDARY Acne Lesion Counts Total Global Face - Week 12 |
24.8; 23.3 | — |
| SECONDARY Investigator Global Acne Assessment - Baseline |
2.55; 2.51 | — |
| SECONDARY Investigator Global Acne Assessment - Week 1 |
2.35; 2.34 | — |
| SECONDARY Investigator Global Acne Assessment - Week 2 |
2.23; 2.11 | — |
| SECONDARY Investigator Global Acne Assessment - Week 4 |
2.08; 1.87 | — |
| SECONDARY Investigator Global Acne Assessment - Week 8 |
1.88; 1.70 | — |
| SECONDARY Investigator Global Acne Assessment - Week 12 |
1.77; 1.59 | — |
Eligibility Criteria
Inclusion Criteria
- Has mild to moderate acne
- Has 10 - 100 pimples, 10 - 50 inflamed red pimples, up to 2 raised bumps and no cysts
- In general good health
- Must avoid excessive sun exposure and any light treatments or any professional or aesthetic spa-like procedures
- Must not be pregnant, nursing or intend to become pregnant during the study
- Must agree to practice a medically acceptable form of birth control.
- Must be able to read, speak, write and understand English
Exclusion Criteria
- Allergies or sensitivities to product ingredients or to light
- Has severe acne or pre-existing dermatological facial condition
- Has an uncontrolled disease or immune deficient disorder
- Is pregnant, breast-feeding or intending to become pregnant
- Has been taking prescription drug medication for acne or antibiotics for the past 6 months
Data sourced from ClinicalTrials.gov (NCT02698436). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.